Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Staccato Loxapine for Inhalation in Subjects on Chronic, Stable Antipsychotic Regimens

X
Trial Profile

Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Staccato Loxapine for Inhalation in Subjects on Chronic, Stable Antipsychotic Regimens

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 17 Mar 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Loxapine (Primary)
  • Indications Schizophrenia
  • Focus Pharmacokinetics
  • Sponsors Alexza Pharmaceuticals
  • Most Recent Events

    • 27 May 2010 Results of this and another phase I loxapine safety trial (700043576) will be presented at the 163rd Annual Scientific Sessions of the American Psychiatric Association, according to an Alexza Pharmaceuticals media release.
    • 26 May 2010 Tolerability results, with respect to the incidence of cardiovascular adverse events, presented at the 163rd Annual Meeting of the American Psychiatric Association.
    • 08 Nov 2007 New trial record.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top